George Kulik, DVM, PhD

About Me

George Kulik Lab - Designing more effective therapies for advanced prostate and other therapy-resistant cancers.

Research

Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling.. Sastry KS, Chouchane AI, Wang E, Kulik G, Marincola FM, Chouchane L. Cell Death Dis. 2017 06; 8(6):e2844.
Yin Yang 1 promotes mTORC2-mediated AKT phosphorylation.. Zhang Q, Wan M, Shi J, Horita DA, Miller LD, Kute TE, Kridel SJ, Kulik G, Sui G. J Mol Cell Biol. 2016 Jun; 8(3):232-43.
Personalized prostate cancer therapy based on systems analysis of the apoptosis regulatory network.. Kulik G. Asian J. Androl. ; 17(3):471-4.
Targeting proapoptotic protein BAD inhibits survival and self-renewal of cancer stem cells.. Sastry KS, Al-Muftah MA, Li P, Al-Kowari MK, Wang E, Ismail Chouchane A, Kizhakayil D, Kulik G, Marincola FM, Haoudi A, Chouchane L. Cell Death Differ. 2014 Dec; 21(12):1936-49.
Systems modeling of anti-apoptotic pathways in prostate cancer: psychological stress triggers a synergism pattern switch in drug combination therapy.. Sun X, Bao J, Nelson KC, Li KC, Kulik G, Zhou X. PLoS Comput. Biol. 2013; 9(12):e1003358.

View More Publications